UsluAUInalSBaltaS. Assessment of platelet-lymphocyte ratio based on EDTA-dependent pseudothrombocytopenia. Angiology. 2015. doi: 10.1177/0003319715591331.
2.
AkbogaMKCanpolatUYaylaCOzcanFOzekeOTopalogluSArasD. Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology. 2015. doi: 10.1177/0003319715583186.
3.
BanfiGSalvagnoGLLippiG. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin Chem Lab Med. 2007;45(5):565–576.
4.
LippiGPlebaniM. EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact. Clin Chem Lab Med. 2012;50(8):1281–1285.
5.
SchrezenmeierHMullerHGunsiliusEHeimpelHSeifriedE. Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis. Thromb Haemost. 1995;73(3):506–513.
6.
RobierCNeubauerMSternadHRainerF. Hirudin-induced pseudothrombocytopenia in a patient with EDTA-dependent platelet aggregation: report of a new laboratory artefact. Int J Lab Hematol. 2010;32(4):452–453.
7.
BizzaroN. EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol. 1995;50(2):103–109.
